OpenAI announced the launch of Rosalind Biodefense on May 29, 2026, to support trusted developers and government partners in creating biodefense tools and pandemic preparedness capabilities. The initiative aims to ensure that advanced AI capabilities are used to strengthen societal resilience against biological threats. Rosalind Biodefense is designed to enable the development of high-impact defensive applications in the life sciences by leveraging GPT-Rosalind, a frontier reasoning model built for life sciences research. OpenAI will sponsor access to GPT-Rosalind and provide launch support to trusted developers working on frontier biosecurity applications that can bolster societal defenses and build pandemic preparedness. The program includes work across areas such as epidemiological modeling, early detection, screening, preparedness, non-pharmaceutical interventions (NPIs), and other public-health-relevant capabilities. At launch, OpenAI is supporting a first set of organizations building frontier applications across the biological defense stack with GPT-Rosalind. Their work spans the lifecycle of biological threats—from prevention and early detection to societal resilience and medical countermeasure development—and helps demonstrate how frontier AI can support public-health teams, researchers, infrastructure operators, and communities in preparing for future biological risks, whether naturally occurring or synthetic. *Source: [openai](https://openai.com/index/strengthening-societal-resilience-with-rosalind-biodefense/)*